Mohammad Reza Eftekhariyan Ghamsari (Reza Ghamsari)

Years Active: 2021-2023
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Mohammad Reza Eftekhariyan Ghamsari, Joseph Rosenbluh, A Vipin Menon, Nigel H Lovell, Hamid Alinejad-Rokny
Technological Convergence: Highlighting the Power of CRISPR Single-Cell Perturbation Toolkit for Functional Interrogation of Enhancers. Cancers 15 (14) (2023)
Ksenija Nesic, Olga Kondrashova, Rachel M Hurley, Cordelia D McGehee, Cassandra J Vandenberg, Gwo-Yaw Ho, Elizabeth Lieschke, Genevieve Dall, Nirashaa Bound, Kristy Shield-Artin, Marc Radke, Ashan Musafer, Zi Qing Chai, Mohammad Reza Eftekhariyan Ghamsari, Maria I Harrell, Damien Kee, Inger Olesen, Orla McNally, Nadia Traficante, null Australian Ovarian Cancer Study, Anna De Fazio, David D L Bowtell, Elizabeth M Swisher, S John Weroha, Katia Nones, Nicola Waddell, Scott H Kaufmann, Alexander Dobrovic, Matthew J Wakefield, Clare L Scott
Acquired RAD51C Promoter Methylation Loss Causes PARP Inhibitor Resistance in High-Grade Serous Ovarian Carcinoma. Cancer research 81 (18) (2021)

Mohammad Reza Eftekhariyan Ghamsari.css-eqlu8i{font-size:small;padding-left:4px;} (Reza Ghamsari)